Rosen Law Firm, a global investor rights law firm, said it is continuing to investigate potential securities claims on behalf of shareholders of The Ensign Group, Inc. (NASDAQ: ENSG). The investigation concerns allegations that Ensign issued materially misleading business information to investors. The firm is preparing a prospective class action seeking recovery of investor losses and said eligible purchasers may participate through a contingency fee arrangement without paying out-of-pocket fees or costs. The announcement follows a June 8, 2026, Investing.com article about a Hunterbrook report alleging inadequate patient care, manipulated quality metrics, understaffing and payments to executives and affiliates. Ensign shares fell 8.15% that day. Investors can contact Rosen Law Firm through its website, telephone or email to obtain information or join the prospective action.